NAS:CTMX (USA) Also Trade In: Germany

CytomX Therapeutics Inc $ 7.86 -0.18 (-2.24%)

Volume:
687,819
Avg Vol (1m):
1,045,742
Market Cap $:
487.68 Mil
Enterprise Value $:
192.22 Mil
PE Ratio:
0.00
PB Ratio:
7.55
Warning! GuruFocus has detected 2 Severe warning signs with CTMX. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 10Y (-%)

CTMX Stock Institutional Ownership and Insider Ownership - CytomX Therapeutics Inc

62.05
(Mil)
Shares Outstanding
53.55%
33.22 (Mil)
Institutional Ownership
0.99%
0.62 (Mil)
Insider Ownership
98.05%
60.8406 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of CytomX Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
EMBED

Insider ownership (%)

This is the historical insider ownership of CytomX Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

Top Fund Holders